dry eye

4 reasons to use a compounding pharmacyThere are four reasons to opt for a compounding pharmacy instead of reach for your Rx pad: strength, form, ingredients, and function.
How to get non-symptomatic dry eye patients to comply with treatment
How to get non-symptomatic dry eye patients to comply with treatmentDr. Scott Schachter offers advice on how to better manage non-symptomatic dry eye patients and encourage them to comply with your treatment plan
Incorporating meibomian gland imagingAdding this technology can improve your diagnosis and better educate your patients
Exploring link between sleep habits, dry eye
Exploring link between sleep habits, dry eyeSleep position may be correlated with the severity of dry eye symptoms, suggests a new study.
Getting beyond the surface in ocular surface diseaseOcular surface disease (OSD) is a prevalent, chronic, and progressive condition with an often multifactorial etiology. A comprehensive approach to detection, treatment, and monitoring is required.
Contact lenses and dry eye: Cause or remedy?Contact lens wearers are dropping out for comfort and vision reasons. Contact lenses can be considered a significant cause of these symptoms if they contribute to an unstable tear film or trigger inflammatory reactions.
Why accountable contact lens fitting mattersIn order to properly care for our contact lens patients, we have to take responsibility for the changes that are occurring in the tear film under the lens.
Diagnosing and treating Sjögren's syndrome
Diagnosing and treating Sjögren's syndromeSjögren’s syndrome is underdiagnosed and seriously impacts the ocular surface and quality of life and places the patient at risk for multisystem involvement. Optometry’s role in identification, diagnosis and collaborative long-term management is an important one. Earlier attention to symptoms leading to diagnosis and collaboration with other health professionals will ensure better quality of life for our patients.
IL-1 receptor inhibitor fails on ocular itching endpointIsunakinra, an interleukin-1 signaling inhibitor designed for topical ophthalmic administration, did not meet the primary endpoint in a phase III clinical trial for the treatment of moderate-to-severe allergic conjunctivitis.
3 ways ODs can combat 1-800-EYE-EXAM
3 ways ODs can combat 1-800-EYE-EXAMThe recent announcement that 1-800 Contacts has partnered with online eye exam provider Opternative to offer consumers eye exams online has rocked the optometry community. What can we learn from this announcement, and what should we do?